Esther Zamora
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 4
- Cancer Cells and Metastasis 3
- Cancer Risks and Factors 2
- Cancer Research top 10%
-
- Advanced Breast Cancer Therapies 3
- Genetics top 10%
-
- Immunotherapy and Immune Responses 3
-
- Fibroblast Growth Factor Research 2
- Co-authors
- Javier CortésSara M. TolaneyMaura N. DicklerMartin FrenzelVéronique DièrasClifford A. HudisDenise A. YardleyJoyce O’Shaughnessy
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- SpainPalestinian TerritoryUnited States
In The Last Decade
Esther Zamora
22 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 756
- Cancer Research 277
- Pulmonary and Respiratory Medicine 576
- Genetics 137
- Immunology 76
Countries citing papers authored by Esther Zamora
This map shows the geographic impact of Esther Zamora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Zamora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Zamora more than expected).
Fields of papers citing papers by Esther Zamora
This network shows the impact of papers produced by Esther Zamora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Zamora. The network helps show where Esther Zamora may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esther Zamora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 63 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 8 | |
| 15 | MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancerbreakdown → | 2017 | 490 |
| 16 | 2017 | 118 | |
| 17 | 2014 | 1 | |
| 18 | 2013 | 15 | |
| 19 | 2013 | 3 | |
| 20 | 2012 | 224 |
About Esther Zamora
Esther Zamora is a scholar working on Oncology, Cancer Research and Pharmacology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers), Fibroblast Growth Factor Research (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Oncology (756 citations), Cancer Research (277 citations) and Pulmonary and Respiratory Medicine (576 citations). Esther Zamora has collaborated with scholars based in Spain, Palestinian Territory and United States. Frequent co-authors include Javier Cortés, Sara M. Tolaney, Maura N. Dickler, Martin Frenzel, Véronique Dièras, Clifford A. Hudis, Denise A. Yardley, Joyce O’Shaughnessy, Debra A. Patt and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.